Tracheoesophageal Fistula

← Back to Index (🍴 Gastroenterology)

Definition And Epidemiology

Embryology And Pathophysiology

Classification

Type (Gross/Vogt) Anatomical Description Frequency Radiographic Finding
Type A (Type 2) Pure EA (isolated); "long gap"; no fistula. 7-8% Gasless, scaphoid abdomen.
Type B (Type 3A) EA with proximal TEF. 1-2% Gasless abdomen.
Type C (Type 3B) EA with distal TEF (most common). 85-88.8% Gastric air present on radiograph.
Type D (Type 3C) EA with both proximal and distal TEF. 1-2.8% Gastric air present on radiograph.
Type E (Type H) H-type TEF (fistula without EA). 4-4.2% Gastric air present on radiograph.

Clinical Presentation

Antenatal And Neonatal Signs

H-Type Presentation

Associated Anomalies

Anomalies are present in up to 50% of infants with EA/TEF.

Category Specific Associations
VACTERL Association Vertebral, Anorectal, Cardiac, Tracheal, Esophageal, Renal, and Limb anomalies (present in 15% of cases).
Cardiac Anomalies Most common association (30-32%); includes ventricular septal defect, patent ductus arteriosus, and tetralogy of Fallot.
Other Systems Vertebral anomalies (24%), imperforate anus (10%).
Syndromic CHARGE syndrome, Feingold syndrome, Trisomy 18, and Trisomy 21.

Diagnostic Evaluation

Bedside And Radiographic

Specialized Diagnostics

Management Protocol

Initial Stabilization

Surgical Intervention

Complications And Prognosis

Postoperative Complications

Phase Complications
Early Anastomotic leak, anastomotic stricture (most common, requiring balloon dilatations), recurrent TEF, mediastinitis, pneumonitis.
Late Severe gastroesophageal reflux disease (GERD) requiring Nissen fundoplication. Tracheomalacia presenting with a "barking" cough or cyanotic spells. Barrett's esophagus and long-term dysphagia.

Spitz Classification For Survival

Survival heavily depends on birth weight (BW) and concurrent major congenital heart disease (CHD).

Group Clinical Criteria Survival Rate
Group I BW ≥ 1500 g; no major CHD. 97%.
Group II BW < 1500 g OR major CHD present. 59%.
Group III BW < 1500 g AND major CHD present. 22%.